Silvia Filimon
Research Subjects
Research Interests
Silvia Filimon has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Grejdieru
Department of Cardiology, “Nicolae Testemitanu” State University of Medicine and Pharmacy, 2004 Chisinau, Moldova
1 shared publication Aliona Grivenco
1 shared publicationAndreea Filimon
1 shared publicationDorin Lisii
1 shared publication- Elena Samohvalov
IP Universitatea de Stat de Medicină și Farmacie “Nicolae Testemițanu”; IMSP Spitalul Clinic Municipal „Sfânta Treime
1 shared publication - Eleonora Vataman
IMSP Institutul de Cardiologie
1 shared publication
Latest Publications
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 318-328
Clinical characteristics and long-term management of hospitalized patients with acute heart failure: results of the ESC Heart Failure Long-Term Registry Republic of Moldova
Purpose. description and analysis of the hospitalized patients with acute heart failure, who were included in the ESC Heart Failure Long-Term Registry Republic of Moldova (ESC-HF-LT Registry RM), their gender differences and the evolution of adherence to optimal drug treatment over the last ten years in the RM. Material and methods. The study group consisted of 254 patients older than 18 years, hospitalized with acute heart failure (HF) during the period 2011 - 2014 in 2 centers in the Republic of Moldova. Results. The majority of hospitalized patients were men (64.9%), with a higher mean age in women. The main cause of HF was ischemic heart disease. Arterial hypertension was more common in women: 80.9% vs 67.9% in men, p less than 0.05, but among men there were fewer smokers and alcohol drinkers. The main cause of admission was exacerbated heart failure, in patients included in the ESC-HF-LT registry. The mean LV EF values were higher in women: 44.1% vs 37.3% in men, p less than 0.01. Mortality and readmission rates at 12 months were similar in the female and male patient groups. Conclusion. The clinical characteristics and 12-month outcomes of patients hospitalized with heart failure in the Republic of Moldova were similar compared to patients from other countries included in the ESC Heart Failure Longterm Registry. The rate of drug prescription for the optimal treatment of heart failure in recent years has been high, especially for ACE inhibitors/ARBs and beta-blockers, with a positive trend in the prescription of SGLT-2 inhibitors.
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 318-328
Clinical characteristics and long-term management of hospitalized patients with acute heart failure: results of the ESC Heart Failure Long-Term Registry Republic of Moldova
Purpose. description and analysis of the hospitalized patients with acute heart failure, who were included in the ESC Heart Failure Long-Term Registry Republic of Moldova (ESC-HF-LT Registry RM), their gender differences and the evolution of adherence to optimal drug treatment over the last ten years in the RM. Material and methods. The study group consisted of 254 patients older than 18 years, hospitalized with acute heart failure (HF) during the period 2011 - 2014 in 2 centers in the Republic of Moldova. Results. The majority of hospitalized patients were men (64.9%), with a higher mean age in women. The main cause of HF was ischemic heart disease. Arterial hypertension was more common in women: 80.9% vs 67.9% in men, p less than 0.05, but among men there were fewer smokers and alcohol drinkers. The main cause of admission was exacerbated heart failure, in patients included in the ESC-HF-LT registry. The mean LV EF values were higher in women: 44.1% vs 37.3% in men, p less than 0.01. Mortality and readmission rates at 12 months were similar in the female and male patient groups. Conclusion. The clinical characteristics and 12-month outcomes of patients hospitalized with heart failure in the Republic of Moldova were similar compared to patients from other countries included in the ESC Heart Failure Longterm Registry. The rate of drug prescription for the optimal treatment of heart failure in recent years has been high, especially for ACE inhibitors/ARBs and beta-blockers, with a positive trend in the prescription of SGLT-2 inhibitors.
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 115-121
What is hidden after Acute Coronary Syndrome?
Stress ("Tako-Tsubo") cardiomyopathy or Takotsubo syndrome (TTS), is characterized by acute but rapidly reversible LV systolic dysfunction in the absence of atherosclerotic coronary artery disease, triggered by strong psychological, physical or iatrogenic stress. Takotsubo syndrome is a complex and still poorly recognized heart disease with a wide spectrum of possible clinical presentations. Despite its reversibility, it is associated with serious adverse in-hospital events and high complication rates during follow-up. Multimodal imaging is helpful for establishing the diagnosis, guiding therapy, and stratifying prognosis of TTS patients in both the acute and post-acute phase. This article describes the clinical case of a 67-year-old woman who, after a strong emotional stress, presented with clinical manifestations of ACS. Following laboratory tests and investigations (ECG, Echocardiography, Chest X-ray, Coronary angiography, Ventriculography) the diagnosis of Takotsubo Syndrome was established. Based on treatment with beta-adrenoblockers, anticoagulants, dual antiplatelet therapy (Aspirin+Clopidogrel), nitrates, statins, metabolic drugs (Mildronate), the patient"s condition improved, with the recovery of left ventricular systolic function.
- 1 November 2025
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences"
- No. 2(82),p. 115-121
What is hidden after Acute Coronary Syndrome?
Stress ("Tako-Tsubo") cardiomyopathy or Takotsubo syndrome (TTS), is characterized by acute but rapidly reversible LV systolic dysfunction in the absence of atherosclerotic coronary artery disease, triggered by strong psychological, physical or iatrogenic stress. Takotsubo syndrome is a complex and still poorly recognized heart disease with a wide spectrum of possible clinical presentations. Despite its reversibility, it is associated with serious adverse in-hospital events and high complication rates during follow-up. Multimodal imaging is helpful for establishing the diagnosis, guiding therapy, and stratifying prognosis of TTS patients in both the acute and post-acute phase. This article describes the clinical case of a 67-year-old woman who, after a strong emotional stress, presented with clinical manifestations of ACS. Following laboratory tests and investigations (ECG, Echocardiography, Chest X-ray, Coronary angiography, Ventriculography) the diagnosis of Takotsubo Syndrome was established. Based on treatment with beta-adrenoblockers, anticoagulants, dual antiplatelet therapy (Aspirin+Clopidogrel), nitrates, statins, metabolic drugs (Mildronate), the patient"s condition improved, with the recovery of left ventricular systolic function.